Buy call to Dr. Reddy Lab – Target Price – Rs. 4925 / –
ICICI Securities Reddy Laboratories has been given a buy call and the target price is 4925 / -. The current market price is Rs. 4610 / -.The period for this is given as 1 year.
The company was established in 1984 and is a large cap company. Working in the pharmaceutical sector and with a market capitalization of Rs. 71,762.83 crore.
The major products of the company are revenue generation, pharma products, license fees, spent chemicals, service income, scrap.
Total income for the quarter ended March was Rs. 5596.80 crore and in the quarter ended December, the amount was Rs. Rs. 5394.10 crore. This amount was Rs. 4850.80 crore during the same quarter last year.
The company posted a net profit of Rs. 86.50 crore.
The promoter holding of this company is 26.72%, FII – 25.16%, DII – 24.79%.
Disclaimer : This above is third party content and Arthsanket hereby disclaims any and all warranties, express or implied, relating to the same. Arthsanket does not guarantee, vouch for or endorse any of the above content or its accuracy nor is responsible for it in any manner whatsoever. The content does not constitute any investment advice or solicitation of any kind. Users are advised to check with certified experts before taking any investment decision and take all steps necessary to ascertain that any information and content provided is correct, updated and verified
- FedEx Launches New Vietnam Service that Improves Transit to India by One Day
- Club Mahindra launches Discover India NFTs
- Godrej Interio launches Posture Perfect – a breakthrough chair design
- ‘Maharashtra in nation building’ A grand program of entrepreneurs held at Nicmar University, Pune
- Godrej & Boyce launches ‘Conscious Collective’ an annual event toredefine sustainable living through design
